A study investigating whether a lesser known and under-reported side-effect of some chemotherapy medicines has a greater ...

Discover how cancer cells survive in low-glucose environments and evade chemotherapy-induced death. New study sheds light on ...

According to the latest study shared by the team, their gold-based cancer drug helped in significantly slowing down cancer ...

Many cancer drugs are antimetabolites, which interfere with the cellular processes necessary for tumor growth and survival.

With ponatinib (Iclusig) receiving an accelerated approval from the FDA earlier this year for the treatment of Philadelphia ...

When a common infection made it harder for a toddler to breathe, a Sheboygan family took him to an urgent care clinic. Its ...

A study by NYU Langone Health and its Perlmutter Cancer Center uncovered how cancer cells survive in low-glucose environments ...

Gold is shining in a surprising new way—not as jewelry, but as a potential cancer treatment. Researchers from RMIT University ...

Algorae Pharmaceuticals says its new AI-168 drug candidate shows early potential to improve on treatments to protect the ...

It is also under review by the NMPA for locally advanced or metastatic EGFR-mutant NSCLC, for second-line use after either an ...

University Hospital Coventry is undertaking a trial using a machine known as Aura-10 to check whether all the cancer has been ...

This week saw significant funding activity across diverse sectors, from oncology drug manufacturing to electric vehicle leasing. Here's a roundup of key deals that grabbed attention.